Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).

Trial Profile

Safety and efficacy study using ABT-335 [Choline fenofibrate] (investigational drug) in combination with atorvastatin, to study the effects on thickening of the blood vessel wall in patients with abnormal lipid (fat) levels in the blood (FIRST).

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jul 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Choline fenofibrate (Primary) ; Atorvastatin
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics; Registrational
  • Acronyms FIRST
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 10 Mar 2013 Primary endpoint 'Intima-media-thickness' has not been met.
    • 10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top